Kamal N. Menghrajani, MD, is a hematologist/medical oncologist in New York, NY, with board certifications in Hematology, Medical Oncology, and Internal Medicine. She earned her MD from the University of North Carolina at Chapel Hill School of Medicine (2012), completed Internal Medicine residency at the University of Michigan, and fellowship (chief fellow) in Hematology and Medical Oncology at Memorial Sloan Kettering Cancer Center. Her clinical focus includes leukemia, myeloproliferative neoplasms (MPNs), and myelodysplastic syndrome (MDS). Her research centers on clonal hematopoiesis, cancer genomics, and investigator-initiated clinical trials. She served as a 2023–2024 White House Fellow with the Cancer Moonshot and Health Outcomes teams at the White House Office of Science and Technology Policy. NPI: 1184987703.
Attending Physician
Attending Physician
Medical School
Residency
Fellowship